These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 12173063

  • 1. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
    Müller D, Lang S, Roskrow M, Wollenberg B.
    Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
    [Abstract] [Full Text] [Related]

  • 2. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 3. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL.
    Cancer; 2001 Jun 01; 91(11):2136-47. PubMed ID: 11391595
    [Abstract] [Full Text] [Related]

  • 4. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
    Reichert TE, Day R, Wagner EM, Whiteside TL.
    Cancer Res; 1998 Dec 01; 58(23):5344-7. PubMed ID: 9850063
    [Abstract] [Full Text] [Related]

  • 5. T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma.
    Cardi G, Heaney JA, Schned AR, Phillips DM, Branda MT, Ernstoff MS.
    Cancer Res; 1997 Aug 15; 57(16):3517-9. PubMed ID: 9270022
    [Abstract] [Full Text] [Related]

  • 6. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
    Kuss I, Saito T, Johnson JT, Whiteside TL.
    Clin Cancer Res; 1999 Feb 01; 5(2):329-34. PubMed ID: 10037182
    [Abstract] [Full Text] [Related]

  • 8. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M, Bier H, Schirlau K, Friebe-Hoffmann U, Scheckenbach K, Balz V, Whiteside TL, Hoffmann TK.
    Oral Oncol; 2006 Aug 01; 42(7):691-7. PubMed ID: 16527515
    [Abstract] [Full Text] [Related]

  • 9. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 10. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
    Lockhart DC, Chan AK, Mak S, Joo HG, Daust HA, Carritte A, Douville CC, Goedegebuure PS, Eberlein TJ.
    Surgery; 2001 Jun 01; 129(6):749-56. PubMed ID: 11391375
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
    Kono K, Ressing ME, Brandt RM, Melief CJ, Potkul RK, Andersson B, Petersson M, Kast WM, Kiessling R.
    Clin Cancer Res; 1996 Nov 01; 2(11):1825-8. PubMed ID: 9816136
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.
    Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R.
    Cancer Res; 1993 Dec 01; 53(23):5610-2. PubMed ID: 8242612
    [Abstract] [Full Text] [Related]

  • 13. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W, Steinschifter W, Gotschuli A, Schauenstein E, Schauenstein K.
    Laryngorhinootologie; 1998 Oct 01; 77(10):564-8. PubMed ID: 9842520
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M.
    Cancer Res; 1992 Nov 01; 52(21):5913-20. PubMed ID: 1382847
    [Abstract] [Full Text] [Related]

  • 16. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT, Carey TE.
    J Natl Cancer Inst Monogr; 1992 Nov 01; (13):67-74. PubMed ID: 1389697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M, Pauli C, Stein M, Chaubal S, Wollenberg B.
    Anticancer Res; 2003 Nov 01; 23(2B):1467-71. PubMed ID: 12820411
    [Abstract] [Full Text] [Related]

  • 19. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
    Albers AE, Visus C, Tsukishiro T, Ferris RL, Gooding W, Whiteside TL, De Leo AB.
    Clin Cancer Res; 2006 Apr 15; 12(8):2394-403. PubMed ID: 16638844
    [Abstract] [Full Text] [Related]

  • 20. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
    Matsuda M, Petersson M, Lenkei R, Taupin JL, Magnusson I, Mellstedt H, Anderson P, Kiessling R.
    Int J Cancer; 1995 Jun 09; 61(6):765-72. PubMed ID: 7790109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.